Clinical trial
Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That…
NCT00002583 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00002583 |
|---|---|
| Title | Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed |
| Official title | A Phase III Prospective Randomized Study of Adjuvant Chemotherapy With Vinorelbine and Cisplatin in Completely Resected Non-Small Cell Lung Cancer With Companion Tumour Marker Evaluation |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH SWOG Cancer Research Network Eastern Cooperative Oncology Group Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, vinorelbine ditartrate |
| Enrollment | 482 |
| Start date | Jul 7, 1994 |
| Primary completion | Apr 25, 2004 |
| Completion | Dec 21, 2009 |
| First posted | Apr 22, 2004 |
| Last update posted | Apr 3, 2020 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: